Couling John D

CIK 00018940521 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001894052

Recent Transactions

50 trades

Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-16$66.62/sh−2,612→ 129,708 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2025-12-15−6,825→ 0 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15+25,633→ 133,698 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2025-12-15+56,440→ 56,440 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2025-12-15+12,816→ 12,816 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15$67.54/sh−8,203→ 132,320 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15+6,825→ 140,523 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-11$68.75/sh−7,273→ 108,065 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-11-20$66.12/sh−6,164→ 115,338 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-05-05$75.04/sh−675→ 121,151 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-12-16+36,446→ 36,446 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16$79.18/sh−11,703→ 121,826 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16+20,733→ 127,539 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16+5,990→ 133,529 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2024-12-16+10,366→ 10,366 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2024-12-16−5,990→ 0 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-25$80.50/sh−7,000→ 106,806 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-11-25−7,000→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-25$64.60/sh+7,000→ 113,806 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-11-22−8,000→ 7,000 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-22$80.00/sh−48,000→ 106,806 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-22$81.00/sh−2,000→ 106,806 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-11-22−40,000→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-22$64.60/sh+8,000→ 154,806 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-11-22$33.15/sh+40,000→ 146,806 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$80.81/sh−33,560→ 108,519 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$62.32/sh+21,120→ 142,079 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-09−21,120→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-09−12,440→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-09−21,120→ 0 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$80.81/sh−33,560→ 108,519 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$62.32/sh+21,120→ 142,079 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$42.98/sh+12,440→ 120,959 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-09−12,440→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-09$42.98/sh+12,440→ 120,959 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-08−50,000→ 12,440 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-08$42.98/sh+50,000→ 158,519 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-08$80.00/sh−50,000→ 108,519 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-08−50,000→ 12,440 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-08$42.98/sh+50,000→ 158,519 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-08$80.00/sh−50,000→ 108,519 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-18$87.49/sh−1,488→ 108,519 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2023-12-15−5,427→ 0 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2023-12-15+30,327→ 30,327 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15$88.60/sh−9,093→ 110,007 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15+5,427→ 119,100 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15+17,303→ 113,673 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2023-12-15+8,651→ 8,651 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-11-15$88.58/sh−79→ 96,370 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-05-15$83.87/sh−278→ 96,245 total

Companies

Dolby Laboratories, Inc.
SVP, Entertainment
$DLB

Recent Filings

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103

View on SEC.gov